Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer

Concetta De Cicco, Laura Ravasi, Laura Zorzino, Maria Teresa Sandri, Edoardo Botteri, Fabrizio Verweij, Donatella Granchi, Ottavio De Cobelli, Giovanni Paganelli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds